January 8, 2025 12:06 PM ESTUpdated 04:33 PM

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

Kyle LaHucik

Senior Reporter

Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%, the company confirmed to Endpoints News.

CEO Ben …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Aiolos team reunites with $411M for new biotech with obesity drugs from China

Versant unveils Light Horse with $62M and a partnership with Novartis

Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago

After lackluster 2024, biopharma industry prays stalled M&A will finally move into gear

Coave raises €32M Series A despite being two years away from the clinic

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

Gene edit­ing start­up Scribe Ther­a­peu­tics lets go of staff as it preps for the clin­ic

Senior Reporter

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Gene editing startup Scribe Therapeutics lets go of staff as it preps for the clinic